Literature DB >> 24662662

The ratio of (18)F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function.

Tao Yang1, Lei Wang, Chang-Ming Xiong, Jian-Guo He, Yan Zhang, Qing Gu, Zhi-Hui Zhao, Xin-Hai Ni, Wei Fang, Zhi-Hong Liu.   

Abstract

PURPOSE: It is known that patients with pulmonary hypertension (PH) can have elevated F-FDG uptake in the right ventricle (RV) on PET imaging. This study was designed to assess possible relationship between FDG uptake of ventricles and the function/hemodynamics of the RV in patients with PH. PATIENTS AND METHODS: Thirty-eight patients with PH underwent FDG PET imaging in both fasting and glucose-loading conditions. The standard uptake value (SUVs) corrected for partial volume effect in both RV and left ventricle (LV) were measured. The ratio of FDG uptake between RV to LV (SUVR/L) was calculated. Right heart catheterization and cardiac magnetic resonance (CMR) were performed in all patients within 1 week. The FDG uptake levels by the ventricles were compared with the result form the right heart catheterization and CMR.
RESULTS: The SUV of RV (SUVR) and SUV of LV were significantly higher in glucose-loading condition than in fasting condition. In both fasting and glucose-loading conditions, SUVR and SUVR/L showed reverse correlation with right ventricular ejection fraction derived from CMR. In addition, in both fasting and glucose-loading conditions, SUVR and SUVR/L showed positive correlations with pulmonary vascular resistance. However, only SUVR/L in glucose-loading condition could independently predict right ventricular ejection fraction after adjusted for age, body mass index, sex, mean right atrial pressure, mean pulmonary arterial pressure, and pulmonary vascular resistance (P = 0.048).
CONCLUSIONS: The FDG uptake of RV increases with decreased right ventricular function in patients with PH. Increased FDG uptake ratio between RV and LV might be useful to assess the right ventricular function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662662     DOI: 10.1097/RLU.0000000000000422

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  18 in total

1.  Right ventricular dyssynchrony in pulmonary hypertension: Phase analysis using FDG-PET imaging.

Authors:  Lei Wang; Weihua Zhou; Yu Liang; Yong Yang; Ernest V Garcia; Ji Chen; Wei Fang
Journal:  J Nucl Cardiol       Date:  2015-12-29       Impact factor: 5.952

Review 2.  Update on novel targets and potential treatment avenues in pulmonary hypertension.

Authors:  John C Huetsch; Karthik Suresh; Meghan Bernier; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-02       Impact factor: 5.464

3.  Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake.

Authors:  Brian B Graham; Rahul Kumar; Claudia Mickael; Linda Sanders; Liya Gebreab; Kendra M Huber; Mario Perez; Peter Smith-Jones; Natalie J Serkova; Rubin M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-26       Impact factor: 5.464

Review 4.  FDG PET imaging for identifying pulmonary hypertension and right heart failure.

Authors:  Ali Ahmadi; Hiroshi Ohira; Lisa M Mielniczuk
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

Review 5.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

6.  The characterization and prognostic significance of right ventricular glucose metabolism in non-ischemic dilated cardiomyopathy.

Authors:  Lei Wang; Xinghong Ma; Liwei Xiang; Minjie Lu; Chaowu Yan; Shihua Zhao; Wei Fang
Journal:  J Nucl Cardiol       Date:  2015-08-08       Impact factor: 5.952

7.  Simultaneous determination of dynamic cardiac metabolism and function using PET/MRI.

Authors:  Gregory P Barton; Lauren Vildberg; Kara Goss; Niti Aggarwal; Marlowe Eldridge; Alan B McMillan
Journal:  J Nucl Cardiol       Date:  2018-05-01       Impact factor: 5.952

8.  Multimodal assessment of right ventricle overload-metabolic and clinical consequences in pulmonary arterial hypertension.

Authors:  Remigiusz Kazimierczyk; Lukasz A Malek; Piotr Szumowski; Stephan G Nekolla; Piotr Blaszczak; Dorota Jurgilewicz; Marcin Hladunski; Bozena Sobkowicz; Janusz Mysliwiec; Ryszard Grzywna; Wlodzimierz J Musial; Karol A Kaminski
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-10       Impact factor: 5.364

Review 9.  Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2021-01-31       Impact factor: 2.374

10.  Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension.

Authors:  Fotios Spyropoulos; Zoe Michael; Benjamin Finander; Sally Vitali; Kosmas Kosmas; Panagiotis Zymaris; Brian T Kalish; Stella Kourembanas; Helen Christou
Journal:  Front Cardiovasc Med       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.